The US Food and Drug Administration (FDA) has issued an advisory against two supplement products due to the presence of hidden drug ingredients.
FDA is advising consumers not to purchase or use Force Forever, a product marketed for joint pain. It is being sold on various websites and may also be available in some retail stores.
According to the health agency, laboratory analysis has confirmed that Force Forever contains diclofenac and dexamethasone, which are not listed on the product label.
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID), and dexamethasone is a corticosteroid.
The agency said diclofenac can increase the risk of heart attack, stroke, and gastrointestinal damage, while dexamethasone may impair immune function, raise blood sugar levels, and cause muscle or psychiatric issues.
Prolonged or high-dose use of dexamethasone can also suppress the adrenal gland and combining it with other medications may lead to serious side effects.
FDA said consumers using Force Forever should immediately consult with a healthcare professional to safely discontinue the product. Healthcare professionals can assess the risks of corticosteroid withdrawal and evaluate whether adrenal suppression is present.
THERMO SHOCK is being sold as a weight loss product. It is also available online and may also be available in some retail stores.
FDA laboratory analyses have confirmed that THERMO SHOCK contains 1,3-dimethylamylamine (1,3-DMAA) and synephrine, which are not listed on the product label.
1,3-DMAA can elevate blood pressure and increase the risk of cardiovascular issues, such as heart attack, shortness of breath, and chest tightness.
Synephrine, especially when combined with caffeine, may also lead to cardiovascular effects like increased heart rate and blood pressure.
Consumers who experience any adverse effects should seek advice from a healthcare professional immediately.
In addition, the American health regulator said that healthcare professionals and consumers should report any adverse events or side effects related to the use of both the products to its MedWatch Safety Information and Adverse Event Reporting Program.
Recently, the FDA advised consumers against purchasing or using HON-E-LING, a product marketed for sexual enhancement on various websites and potentially in some retail stores.
FDA’s laboratory analysis revealed that HON-E-LING contains sibutramine and sildenafil, which are not listed on the product label.
